BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 36376874)

  • 1. Spatial multi-omics analyses of the tumor immune microenvironment.
    Hsieh WC; Budiarto BR; Wang YF; Lin CY; Gwo MC; So DK; Tzeng YS; Chen SY
    J Biomed Sci; 2022 Nov; 29(1):96. PubMed ID: 36376874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omics-Based Investigations of Breast Cancer.
    Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The "-OMICS" facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkers.
    Donnelly D; Aung PP; Jour G
    Semin Cancer Biol; 2019 Dec; 59():165-174. PubMed ID: 31295564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial omics techniques and data analysis for cancer immunotherapy applications.
    Zhang Y; Lee RY; Tan CW; Guo X; Yim WW; Lim JC; Wee FY; Yang WU; Kharbanda M; Lee JJ; Ngo NT; Leow WQ; Loo LH; Lim TK; Sobota RM; Lau MC; Davis MJ; Yeong J
    Curr Opin Biotechnol; 2024 Jun; 87():103111. PubMed ID: 38520821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
    Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
    BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in research on tumor microenvironment-based spatial omics technologies.
    Xie F; Xi N; Han Z; Luo W; Shen J; Luo J; Tang X; Pang T; Lv Y; Liang J; Liao L; Zhang H; Jiang Y; Li Y; He J
    Oncol Res; 2023; 31(6):877-885. PubMed ID: 37744276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.
    Zeng D; Ye Z; Shen R; Yu G; Wu J; Xiong Y; Zhou R; Qiu W; Huang N; Sun L; Li X; Bin J; Liao Y; Shi M; Liao W
    Front Immunol; 2021; 12():687975. PubMed ID: 34276676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell omics traces the heterogeneity of prostate cancer cells and the tumor microenvironment.
    Yu X; Liu R; Gao W; Wang X; Zhang Y
    Cell Mol Biol Lett; 2023 May; 28(1):38. PubMed ID: 37161356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining Cell Identity with Single-Cell Omics.
    Mincarelli L; Lister A; Lipscombe J; Macaulay IC
    Proteomics; 2018 Sep; 18(18):e1700312. PubMed ID: 29644800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of Single-Cell Omics in Tumor Immunology.
    Liu J; Qu S; Zhang T; Gao Y; Shi H; Song K; Chen W; Yin W
    Front Immunol; 2021; 12():697412. PubMed ID: 34177965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy.
    Gohil SH; Iorgulescu JB; Braun DA; Keskin DB; Livak KJ
    Nat Rev Clin Oncol; 2021 Apr; 18(4):244-256. PubMed ID: 33277626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Spatial and Genomic Hierarchy of Tumor Ecosystems Revealed by Single-Cell Technologies.
    Smith EA; Hodges HC
    Trends Cancer; 2019 Jul; 5(7):411-425. PubMed ID: 31311656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of spatial profiling technologies for characterizing the tumor microenvironment in immuno-oncology.
    Hu B; Sajid M; Lv R; Liu L; Sun C
    Front Immunol; 2022; 13():996721. PubMed ID: 36389765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-OMICS approaches in cancer biology: New era in cancer therapy.
    Chakraborty S; Sharma G; Karmakar S; Banerjee S
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167120. PubMed ID: 38484941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Cell RNA Sequencing with Spatial Transcriptomics of Cancer Tissues.
    Ahmed R; Zaman T; Chowdhury F; Mraiche F; Tariq M; Ahmad IS; Hasan A
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facts and Hopes in Using Omics to Advance Combined Immunotherapy Strategies.
    Augustin RC; Cai WL; Luke JJ; Bao R
    Clin Cancer Res; 2024 May; 30(9):1724-1732. PubMed ID: 38236069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors.
    Funingana IG; Bedia JS; Huang YW; Delgado Gonzalez A; Donoso K; Gonzalez VD; Brenton JD; Ashworth A; Fantl WJ
    Semin Immunopathol; 2023 Jan; 45(1):43-59. PubMed ID: 36635516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis.
    Xiao Y; Bi M; Guo H; Li M
    EBioMedicine; 2022 May; 79():104001. PubMed ID: 35439677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial maps of hepatocellular carcinoma transcriptomes reveal spatial expression patterns in tumor immune microenvironment.
    Wang YF; Yuan SX; Jiang H; Li ZX; Yin HZ; Tan J; Dai ZH; Ge CM; Sun SH; Yang F
    Theranostics; 2022; 12(9):4163-4180. PubMed ID: 35673582
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer biomarker discovery and translation: proteomics and beyond.
    Hristova VA; Chan DW
    Expert Rev Proteomics; 2019 Feb; 16(2):93-103. PubMed ID: 30556752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.